Abiopharma

UNISYS CORP (UIS) Reports the reporting period Financial Results UNISYS CORP (UIS) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: $473
• Net Income: $473
• EPS: (0.08)
• Cash and equivalents: $47 Management Commentary: '"The year is progressing well, with our strong second quarter performance building on the good start we had in the first quarter," said Michael Thomson'
  • anticipated by management. Because actual results may differ materially from those expressed or implied by these forward-looking statements, we caution readers not to place undue reliance on these statements. Forward-looking statements in this release and the accompanying presentation include, but are not limited to, statements made in Mr. Thomson's and Ms. McCann's quotations, any projections or expectations of revenue growth, margin expansion, achievement of operational efficiencies and savings, effective use of technology, investments in our solutions and artificial intelligence adoption and innovation, TCV and New Business TCV, the impact of new logo signings, backlog, book-to-bill(4), full-year 2026